	CD39(+)PD-1(+) regulatory T cells in melanoma: key drivers of systemic immunosuppression and prognostic biomarkers. Front Oncol Qiao G, He H, Wang X. PMID: 41426337 [PubMed]
	Global Burden and Trends of Cutaneous Malignant Melanoma in the Elderly Population: Analysis of Global Burden of Disease Study 2021. Clin Cosmet Investig Dermatol Du Z, Li X, Tan W, Wang C, Wang G, Wei H, Pan Y, Wu S, Zhou Q, Lin H. PMID: 41425115 [PubMed]
	Therapeutic properties of plant-derived prebiotics in melanoma. Explor Target Antitumor Ther Kay E, Kazi M, Burton J, Parvathy SN. PMID: 41424605 [PubMed]
	Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801. Clin Transl Oncol Cerezuela-Fuentes P, Piñero-Madrona A, Muñoz-Couselo E, Manzano JL, Berciano-Guerrero MÁ, Majem M, Espinosa E, Soria A, Ayala de Miguel P, García Castaño A, Crespo G, Gutiérrez Sanz L, Aguado de la Rosa C, Fernández-Morales LA, Puértolas T, Fra Rodríguez J, Rodríguez de la Borbolla M, Bellido L, López Castro R, Navarro Pérez V, García Arroyo FR, Villa Guzmán JC, Campos Balea B, Hernández B, Martín Algarra S, Márquez-Rodas I. PMID: 41420791 [PubMed - as supplied by publisher]
	Melanoma treatment in the era of nanotechnology and precision medicine. J Nanobiotechnology da Cruz AF, Colella F, Grasso G, Onesto V, Forciniti S, Ortiz BB, Carnevali F, Siciliano AC, Bove R, Gonçalves Dos Santos J, Iuele H, Zub EC, Gigli G, Del Mercato LL, Camargo de Oliveira C. PMID: 41419864 [PubMed - as supplied by publisher]
	Prospective standardized surveillance of early-stage melanoma on the basis of anatomical staging and molecular profiling: Study design and interim analysis. Surgery Aubrey JM, Kelley J, Khan M, Kolbeinsson H, Liefeld H, Preihs R, Bengel A, Koch C, Martin L, Charchan J, Texley-Quigg K, Melnik M, Wright GP. PMID: 41419392 [PubMed - as supplied by publisher]
	Enhancing Diagnostic Precision in Primary Care: A Multireader Multicase (MRMC) Study of an AI-Powered Handheld Elastic Scattering Spectroscopy Device for Informed Referral Decisions in Melanoma Evaluation. J Clin Aesthet Dermatol Seiverling EV, Shah A, Weinstock MA, Grant-Kels JM, Falk NP, Siegel DM. PMID: 41416030 [PubMed]
	Competing risk analysis of prognosis in patients with uveal melanoma. Discov Oncol Huang R, Chen J, Lyu J, Zhou Q, Lin L. PMID: 41413733 [PubMed - as supplied by publisher]
	Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Patients with Primary Cutaneous Melanoma. Ann Surg Oncol Zijlker LP, Verwer Z, van der Wiel BA, Kuijpers AMJ, Wouters MWJM, van Houdt WJ, van Akkooi ACJ. PMID: 41413281 [PubMed - as supplied by publisher]
	P22 Using VECTRA and AI analysis to monitor paediatric lesions: a review of cases. Br J Dermatol Baird J, Murrell D. PMID: 41412984 [PubMed - indexed for MEDLINE]
	Exploring the Impact of Foods and Dietary Patterns on Melanoma Risk. Cureus Kalavsky M, Abdul Gafoor SM. PMID: 41409372 [PubMed]
	A Case Report of a Comparative Approach in a Patient with Multiple Seborrheic Keratosis: Does It Work for SK-Like Melanoma Screening? Case Rep Dermatol Billah LM, Chiheb S, Mohamed O, Kelati A. PMID: 41409133 [PubMed]
	High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors. J Transl Med Guida M, Apollonio B, Romano L, Spagnolo F, Quaglino P, Depenni R, Pinto R, Squicciarini T, Fucci L, Di Tullio P, Scaini MC, Maccallini MT, Indini A, Troiani T, Natalicchio I, Brugnara S, Lombardo M, Pellegrini C, Queirolo P, Perrone F, Minisini A, Tucci M, Conca R, Costabile S, Macrì M, Tanda E, Croce E, Senetta R, Fava P, Pugliese G, Pellegrini S, Melucci E, Vecchio MD, Caraglia F, Girlando S, De Summa S, Strippoli S, Italian Melanoma Intergroup (IMI). PMID: 41408295 [PubMed - indexed for MEDLINE]
	Dual checkpoint inhibitor therapy versus dual targeted therapy of untreated metastatic BRAF-mutant melanoma: a systematic review of randomised controlled trials. BMJ Open Peinemann F, Baradaran S, Arnolds KB, Hoemberg M. PMID: 41407417 [PubMed - indexed for MEDLINE]
	Evaluating missing outcome data methods for the analysis of the MEL-SELF trial of patient-led surveillance for early-stage melanoma: A simulation study. Contemp Clin Trials Medcalf E, Turner RM, Espinoza D, Zhu L, Bell KJL. PMID: 41407102 [PubMed - as supplied by publisher]
	3D Total Body Photography as a Promising Innovation for Early Skin Cancer Detection: Scoping Review. JMIR Dermatol Baete F, Jakers AL, Delanoye E, Vande Velde N, Voet G. PMID: 41406351 [PubMed - indexed for MEDLINE]
	Nail Matrix Melanoma in Adolescents and Young Adults-A Retrospective Dermoscopic Study. Clin Exp Dermatol Akay BN, Ongun F, Heper AO, Ayça K, Alpat SE, Kocyigit P. PMID: 41403034 [PubMed - as supplied by publisher]
	Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer - results from the Tumor Profiler Melanoma project. NPJ Precis Oncol Mehra T, Menges D, Gosztonyi B, Miglino N, Ring A, Boos L, Sobottka B, Tumor Profiler Consortium, Koelzer VH, Moch H, Toussaint NC, Levesque M, Ramelyte E, Mangana J, Dummer R, Wicki A. PMID: 41402424 [PubMed - as supplied by publisher]
	Correction to "Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study". Cancer PMID: 41400338 [PubMed - in process]
	Unravelling the crosstalk: Anti-fibrotic agents and MAPK inhibitors in the treatment of melanoma. Crit Rev Oncol Hematol Swathika R, Nayak Y, Prasad As B, Nayak UY. PMID: 41397586 [PubMed - as supplied by publisher]

Articles 1 - 20 / 44700

Page 1 of 2235



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy